Page 8 - Practice Research News Today

Chàng trai Hải Phòng giành học bổng tiến sĩ gần 8 tỷ đồng (Nguồn: Vietnamnet) | 01/07/2021, 07:00 Tốt nghiệp xuất sắc hệ kỹ sư tài năng Viện Điện tử Viễn thông, ĐH Bách khoa Hà Nội, Hoàng Văn Trung giành học bổng toàn phần tiến sĩ gần 8 tỷ đồng từ đại học Mỹ. Trung quyết định học tiến sĩ tại Pennsylvania State University vớ...

Presentation will be available on demand as part of the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting BOSTON, MA and WILMINGTON, DE / ACCESSWIRE / June 4, 2021 / MorphoSys US Inc.,

DGAP-News: MorphoSys AG / Key word(s): Miscellaneous04.06.2021 / 19:32 The issuer is solely responsible for the content of this announcement.Media ReleaseMorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refract...

Soiled Linens, Dirty Rooms, and No Housekeeping: Nurses Dish on McLaren Macomb ER Several nurses that work in the McLaren Macomb Emergency Room in Mount Clemens, MI are blowing the whistle on what they see as deplorable working conditions. They recently shared their views on the facility in an anonymous interview, fearing possible retaliation. They depict a nightmare situation that would send shivers down the spine of any nurse. Their testimony has led to a sweeping investigation by the Joint C...

Local nurses allege unsanitary, unsafe conditions within McLaren Macomb ER Nurses are blowing the whistle on conditions inside a local hospital emergency department. They’re alleging that COVID-19 patients not being isolated, potentially exposing other patients and staff. They also say you can regularly see stacks of soiled linens, overflowing garbage, and they allege the waiting room at the McLaren Macomb emergency room is rarely cleaned. and last updated 2021-05-10 21:15:31-04 (WXYZ) â...

frontMIND Study Evaluating Tafasitamab Combination as a  First-line Treatment for Diffuse Large B-Cell Lymphoma PLANEGG/MUNICH, Germany and WILMINGTON, Del., USA - May 11, 2021 - MorphoSys AG (FSE:MOR; NASDAQ:MOR) and Incyte (NASDAQ:INCY) today announced that the first patient has been dosed in the pivotal Phase 3 frontMIND study evaluating tafasitamab and lenalidomide in addition to rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) compared to R-CHOP alone as firs...

MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-line Treatment for Diffuse Large B-Cell Lymphoma ACCESSWIRE 12 May 2021, 06:05 GMT+10 PLANEGG/MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / May 11, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) and Incyte (NASDAQ:INCY) today announced that the first patient has been dosed in the pivotal Phase 3 frontMIND study evaluating tafasitamab and lenalidomide in addition to rituxima...

MorphoSys AG: MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-line Treatment for Diffuse Large B-Cell Lymphoma The frontMIND (NCT04824092) trial is a randomized, double-blind, placebo-controlled, global Phase 3 clinical study in previously untreated high-intermediate and high-risk DLBCL patients that is conducted in partnership with the German Lymphoma Association (GLA), the Italian Lymphoma study group and the US Oncol...

3 March 2021 Fintech disruption trends: a changing payment landscape on the horizon From the rise of software-based payment technology and cross-border e-commerce to an increase in Fraud-as-a-Service, this article explores 2021s main fintech disruption trends What are the main fintech disruption trends impacting the banking sector? From embedded finance to the demand for software-based payment technology, cross-border e-commerce and the the rise...

What are the main Insurtech disruption trends? In this article four leading insurtechs discuss the decline of traditional insurance